The laboratory-clinical interface - Point-of-care testing

被引:88
作者
Kost, GJ
Ehrmeyer, SS
Chernow, B
Winkelman, JW
Zaloga, GP
Dellinger, RR
Shirey, T
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Univ Wisconsin, Madison, WI USA
[4] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA 02115 USA
[5] Bowman Grey Sch Med, Winston Salem, NC USA
[6] Rush Med Coll, Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[7] Nova Biomed, Waltham, MA USA
关键词
bedside diagnosis; microchemistry; point-of-care testing; stat laboratory; therapeutic turnaround time;
D O I
10.1378/chest.115.4.1140
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
POC testing provides an opportunity for clinicians and laboratorians to work together to consider how best to serve the patients within an individual institution. Each health system has unique characteristics relative to patient population, as well as a unique laboratory structure. If physicians, nurses, laboratorians, and pathologists work collaboratively, the best interests of patients will be served. In some institutions that cater to specific patient groups, POC testing may offer clear and distinct advantages. In other institutions with sophisticated transport systems and established rapid response capabilities, the quality resulting from central laboratory testing may outweigh any advantages of bedside testing. Clearly, attention to regulatory issues, QC issues, the importance of proper documentation, proficiency testing, performance enhancement, and cost-effectiveness is requisite. As the technology for diagnostic testing advances through more microcomputerization, microchemistry, and enhanced test menus, the concept of POC testing will need perpetual revisiting. We hope that the information provided here will aid clinicians, laboratorians, and administrators in their quest to best serve their patients.
引用
收藏
页码:1140 / 1154
页数:15
相关论文
共 79 条
[31]  
FELDER RA, 1996, CLIN LAB NEWS, V22, P17
[32]  
FELDER RA, 1996, CLIN LAB NEWS, V22, P10
[33]   CLINICAL USEFULNESS OF THE GLUCOSE-CONCENTRATION IN THE SUBCUTANEOUS TISSUE - PROPERTIES AND PITFALLS OF ELECTROCHEMICAL BIOSENSORS [J].
FISCHER, U ;
REBRIN, K ;
VONWOEDTKE, T ;
ABEL, P .
HORMONE AND METABOLIC RESEARCH, 1994, 26 (11) :515-522
[34]  
GOLDSMITH BM, 1995, AST2P NCCLS
[35]   Current concepts: Erythropoietin therapy [J].
Goodnough, LT ;
Monk, TG ;
Andriole, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :933-938
[36]   CONTINUOUS INTRAARTERIAL BLOOD-GAS AND PH MONITORING IN CRITICALLY ILL PATIENTS WITH SEVERE RESPIRATORY-FAILURE - A PROSPECTIVE, CRITERION STANDARD STUDY [J].
HALLER, M ;
KILGER, E ;
BRIEGEL, J ;
FORST, H ;
PETER, K .
CRITICAL CARE MEDICINE, 1994, 22 (04) :580-587
[37]   Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I [J].
Hamm, CW ;
Goldmann, BU ;
Heeschen, C ;
Kreymann, G ;
Berger, J ;
Meinertz, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1648-1653
[38]   CONTINUOUS MONITORING OF MIXED VENOUS OXYGEN-SATURATION FOR DETECTING ALTERATIONS IN CARDIAC-OUTPUT AFTER DISCONTINUATION OF CARDIOPULMONARY BYPASS [J].
INOMATA, S ;
NISHIKAWA, T ;
TAGUCHI, M .
BRITISH JOURNAL OF ANAESTHESIA, 1994, 72 (01) :11-16
[39]  
JACOBS E, 1993, CLIN CHEM, V39, P1069
[40]  
Jahn M, 1994, MLO Med Lab Obs, V26, P20